Rainbow Children’s Medicare IPO opens today, check GMP, review, valuation and more
For past some time, the GMP of the firm has plunged from Rs 53 to Rs 35. Hence, today's jump is seen as a helping hand for those looking to invest
New Delhi: Healthcare company Rainbow Children’s Medicare initial public offering (IPO) will be launched today on April 27, while the public issue worth Rs 1,595 crore are to be available till April 29, 2022 on the stock exchange.
The Hyderabad-based firm provides healthcare services including pediatric services, gynecology, obstetrics, and more. The issue size for the IPO is Rs 1,580 crore, with a price band of ₹516 to ₹542 apiece. However, the employees under Employee Reservation Category are subjected to a discount of ₹20.
Check details regarding the GMP, review, and valuation:
As per the market experts, shares of the company are available for a premium of Rs 50 in the grey market. For past some time, the GMP of Rainbow Children’s Medicare has plunged from Rs 53 to Rs 35. Hence, today’s jump is seen as a helping hand for those looking to invest in the public issue.
To subscribe, bidders will have to visit their broker’s website or the site or app where they have their Demat account. Select for the company’s IPO (Rainbow Children’s Medicare) and enter their UPI ID and fill the ‘type of investor’ column. NPCI will send you a message regarding confirmation of your bid, requesting you to accept the mandate on your app.
Meanwhile, on the question regarding the investment in the newly launched IPO, Swastika Investmart’s Head of Research Santosh Meena said, “We believe that this exponential rise in profit might not continue in the future. However, the specialized nature of the business, experienced management team, proven ability to attract, train and retain high-caliber medical professionals, under penetration of hospitals in India, make this issue good for long-term investors”.